Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates

This publication has 24 references indexed in Scilit:

• Administration of progestogens to hasten pituitary desensitization after the use of gonadotropin-releasing hormone agonist in in vitro fertilization—a prospective randomized study
  Fertility and Sterility, 1995
• Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin
  American Journal of Obstetrics and Gynecology, 1994
• Pregnancy and birth rates of live infants after in vitro fertilization in women with and without previous in vitro fertilization pregnancies: A study of eight thousand cycles at one center
  American Journal of Obstetrics and Gynecology, 1994
• Endocrinology: The development of functional ovarian cysts during pituitary down-regulation
  Human Reproduction, 1993
• The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials
  Fertility and Sterility, 1992
• Cumulative conception and livebirth rates after in-vitro fertilisation
  The Lancet, 1992
• SHORT COMMUNICATION: The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme
  Human Reproduction, 1992
• Follicle cyst formation following long-acting gonadotropin-releasing hormone analog administration
  Fertility and Sterility, 1989
• MULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONE
  The Lancet, 1985
• INDUCTION OF OVULATION FOR IN-VITRO FERTILISATION USING BUSERELIN AND GONADOTROPINS
  The Lancet, 1984